Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.69 |
| ▸ | CA6 | P23280 | 5/20 | 0.69 |
| ▸ | CA7 | P43166 | 5/20 | 0.69 |
| ▸ | CA9 | Q16790 | 5/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.69 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.69 |
| ▸ | CA2 | P00918 | 4/20 | 0.69 |
| ▸ | CA4 | P22748 | 4/20 | 0.69 |
| ▸ | CA5A | P35218 | 4/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.69 |
| ▸ | CA3 | P07451 | 3/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | CA1 | P00915 | 2/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | RECQL | P46063 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2785775 | 1.00 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| SCHEMBL6303811 | 1.00 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| SCHEMBL6304048 | 1.00 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| Hydrochloric Acid SCHEMBL27773765 | 0.97 | KDM4E (0.71) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28245448 | 0.97 | CA12 (0.65) | CA12CA6CA7CA9CA14 | |
| SCHEMBL254034 | 0.97 | — | — | |
| SCHEMBL28061450 | 0.94 | CA12 (0.61) | CA12CA6CA7CA9CA14 | |
| SCHEMBL239758 | 0.94 | CA12 (0.67) | CA12CA6CA7CA9CA14 | |
| SCHEMBL10937062 | 0.94 | CA12 (0.67) | CA12CA6CA7CA9CA14 | |
| Ammonia Solution, Strong SCHEMBL3074798 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117836013-A | Radiotracer and therapeutic agents that bind to Fibroblast Activation Protein (FAP) | 蓝地诊断有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117120099-A | Dual mode radiotracer and therapy | 慕尼黑工业大学 | 2023-11-24 | — | — | CN | claimed |
| CN-116585494-A | Cancer diagnostic imaging agent | 慕尼黑工业大学 | 2023-08-15 | — | — | CN | claimed |
| US-12030985-B2 | Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof | YALE UNIVERSITY (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | RECODE THERAPEUTICS, INC. | 2024-07-04 | — | — | US | disclosed |
| CN-117836013-A | Radiotracer and therapeutic agents that bind to Fibroblast Activation Protein (FAP) | 蓝地诊断有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117396491-A | Novel peptide-based diagnostic and therapeutic agents | 艾缇亚(上海)制药有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-117120099-A | Dual mode radiotracer and therapy | 慕尼黑工业大学 | 2023-11-24 | — | — | CN | disclosed |
| US-11814464-B2 | Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof | YALE UNIVERSITY (US) | 2023-11-14 | — | — | US | disclosed |
| CN-113573743-B | Cancer diagnostic imaging agent | 慕尼黑工业大学 | 2023-11-07 | — | — | CN | disclosed |
| WO-2023208988-A1 | ANTIBACTERIAL COMPOUNDS ELIMINATING DORMANT BACTERIAL CELLS | UNIVERSITÉ D'AIX-MARSEILLE (FR) | 2023-11-02 | — | — | WO | disclosed |
| US-20040206940-A1 | Novel method of preparing nitrogen macrocycles | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2004-10-21 | — | — | US | disclosed |
| US-20030018198-A1 | Succinimide compounds and use thereof | IDEMITSU KOSAN CO., LTD. (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1243609-A1 | SUCCINIMIDE COMPOUNDS AND USE THEREOF | IDEMITSU KOSAN CO., LTD. (JP) | 2002-09-25 | — | — | EP | disclosed |
| US-5387365-A | Polyamine or polyethyleneimine derivatives with at least one dithiocarboxyl group or salt therof | MIYOSHI YUSHI KABUSHIKI KAISHA (JP) | 1995-02-07 | — | — | US | disclosed |
| US-5347071-A | SCAVENGERS | MIYOSHI YUSHI KABUSHIKI KAISHA (JP) | 1994-09-13 | — | — | US | disclosed |
| EP-0433580-B1 | Metal scavengers and wastewater treatment processes | MIYOSHI YUSHI KK (JP) | 1993-12-22 | — | — | EP | disclosed |
| EP-0211305-B1 | METAL SCAVENGING PROCESS | MIYOSHI YUSHI KABUSHIKI KAISHA (JP) | 1992-07-01 | — | — | EP | disclosed |
| US-4731187-A | Removal of heavy metals from waste water | MIYOSHI YUSHI KABUSHIKI KAISHA | 1988-03-15 | — | — | US | disclosed |
| EP-0211305-A2 | Metal scavenging process | MIYOSHI YUSHI KABUSHIKI KAISHA (JP) | 1987-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030018198-A1 | Succinimide compounds and use thereof | SRM, SMS, SGMS2 | CA12 608/4885CA6 843/4885CA7 1285/4885 |
| US-12030985-B2 | Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof | POLM, PARG, PARN | CA12 2304/4885CA6 1249/4885CA7 2099/4885 |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | LIPA, NPC1L1, NPC1 | CA12 2178/4885CA6 2979/4885CA7 2954/4885 |
| US-11814464-B2 | Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof | POLM, PARG, PARN | CA12 2304/4885CA6 1249/4885CA7 2099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.